Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Wang JZ, Patil V, Liu J, Dogan H, Tabatabai G, Yefet LS, Behling F, Hoffman E, Bunda S, Yakubov R, Kaloti R, Brandner S, Gao A, Cohen-Gadol A, Barnholtz-Sloan J, Skardelly M, Tatagiba M, Raleigh DR, Sahm F, Boutros PC, Aldape K; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G.
Wang JZ, et al. Among authors: bunda s.
Acta Neuropathol. 2023 Jul;146(1):171-172. doi: 10.1007/s00401-023-02584-y.
Acta Neuropathol. 2023.
PMID: 37171636
Free PMC article.
No abstract available.